HomeCompareSYK vs ROP

SYK vs ROP: Dividend Comparison 2026

SYK yields 1.04% · ROP yields 0.96%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ROP wins by $44.8K in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
ROP
ROP
● Live price
0.96%
Share price
$351.96
Annual div
$3.39
5Y div CAGR
61.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$88.1K
Annual income
$33,079.78
Full ROP calculator →

Portfolio growth — SYK vs ROP

📍 ROP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKROP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + ROP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
ROP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
ROP
Annual income on $10K today (after 15% tax)
$81.75/yr
After 10yr DRIP, annual income (after tax)
$28,117.81/yr
At 15% tax rate, ROP beats the other by $21,077.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + ROP for your $10,000?

SYK: 50%ROP: 50%
100% ROP50/50100% SYK
Portfolio after 10yr
$65.7K
Annual income
$20,681.38/yr
Blended yield
31.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
ROP
Analyst Ratings
1
Strong
12
Buy
7
Hold
3
Sell
Consensus: Buy
Price Target
$475.50
+35.1% upside vs current
Range: $365.00 — $575.00
Altman Z
2.6
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
ROP buys
11
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$ROP▼ Sell$15,001 - $50,0002026-02-10
Ro Khanna🏢 House$ROP▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$ROP▼ Sell$1,000 - $15,0002025-08-26
Lisa McClain🏢 House$ROP▲ Buy$1,001 - $15,0002025-07-22
Rob Bresnahan🏢 House$ROP▼ Sell$1,001 - $15,0002025-04-08
Ro Khanna🏢 House$ROP▲ Buy$1,001 - $15,0002024-09-09
Jared Moskowitz🏢 House$ROP▲ Buy$1,001 - $15,0002024-07-05
Ro Khanna🏢 House$ROP▲ Buy$1,001 - $15,0002024-03-25
Ro Khanna🏢 House$ROP▼ Sell$1,001 - $15,0002024-01-10
Jared Moskowitz🏢 House$ROP▲ Buy$1,001 - $15,0002023-12-28
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKROP
Forward yield1.04%0.96%
Annual dividend / share$3.40$3.39
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%61.8%
Portfolio after 10y$43.3K$88.1K
Annual income after 10y$8,282.98$33,079.78
Total dividends collected$21.0K$63.5K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyBuy
Analyst price target$428.67$475.50

Year-by-year: SYK vs ROP ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrROP PortfolioROP Income/yrGap
1← crossover$10,852$152.43$10,856$155.61$4.00ROP
2$11,838$226.03$11,871$255.45$33.00ROP
3$13,004$336.89$13,124$422.40$120.00ROP
4$14,420$505.63$14,749$706.17$329.00ROP
5$16,195$766.09$16,982$1,200.04$787.00ROP
6$18,504$1,175.64$20,260$2,089.32$1.8KROP
7$21,635$1,835.40$25,447$3,769.22$3.8KROP
8$26,082$2,932.10$34,387$7,158.99$8.3KROP
9$32,737$4,829.68$51,423$14,628.76$18.7KROP
10$43,312$8,282.98$88,103$33,079.78$44.8KROP

SYK vs ROP: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

ROPIndustrials

Roper Technologies, Inc. designs and develops software, and engineered products and solutions. The company offers management, campus solutions, diagnostic and laboratory information management, enterprise management, information solutions, transportation management, financial and compliance management, and cloud-based financial analytics and performance management software; cloud-based software to the property and casualty insurance industry; and software, services, and technologies for foodservice operations. It also provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; wireless sensor network and solutions; cloud-based software for the life insurance and financial services industries; supply chain software; health care service and software; RFID card readers; data analytics and information; and pharmacy software solutions. In addition, the company offers precision rubber and polymer testing instruments, and data analysis software; ultrasound accessories; testing and analyzing plastic solutions; dispensers and metering pumps; control valves; precision weighing equipment; automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic measurement systems; automated leak detection equipment; medical devices; products and services for water and gas utilities; and equipment and consumables. It also provides temperature control and emergency shutoff valves; turbomachinery control hardware, software, and services; specialized pumps; flow meter calibrators and controllers; vibration monitoring systems and controls; analytical instrument; drilling power section; and pressure and level sensors. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. The company was incorporated in 1981 and is based in Sarasota, Florida.

Full ROP Calculator →
📬

Get this SYK vs ROP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.